|
Volumn 9, Issue 7, 2001, Pages 1793-1805
|
Disease activated drugs: A new concept for the treatment of asthma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
DEXAMETHASONE;
DISEASE ACTIVATED DRUG;
ISOQUINOLINE DERIVATIVE;
METHACHOLINE;
OZONE;
PHOSPHODIESTERASE IV INHIBITOR;
PRODRUG;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ARTICLE;
ASTHMA;
BRONCHOSPASM;
CONCEPT FORMATION;
CONTROLLED STUDY;
DERIVATIZATION;
DISEASE SEVERITY;
DRUG ACTIVATION;
DRUG RELEASE;
FIBEROPTIC BRONCHOSCOPY;
GUINEA PIG;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
INFLAMMATION;
LUNG LAVAGE;
MALE;
MASS SPECTROMETRY;
NONHUMAN;
PNEUMONIA;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
THROMBOCYTE;
VOLUNTEER;
ANIMALS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BRONCHOALVEOLAR LAVAGE FLUID;
BRONCHOCONSTRICTION;
CELLS, CULTURED;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
GUINEA PIGS;
HUMANS;
HYDROLYSIS;
MAGNETIC RESONANCE SPECTROSCOPY;
MALE;
MASS SPECTROMETRY;
PHOSPHORIC DIESTER HYDROLASES;
RATS;
|
EID: 0034940775
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00077-3 Document Type: Article |
Times cited : (8)
|
References (31)
|